Case report: acute myocardial infarction in the setting of acute transcatheter aortic valve thrombus
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Frontiers Media SA
Abstract
We describe a case of valve thrombosis and a subsequent thromboembolic event within only 10 days of transcatheter aortic valve implantation (TAVI). Postprocedural anticoagulants are not standard of care medications post-TAVI in patients without atrial fibrillation. Valve thrombosis is an indication to initiate anticoagulation to resolve and prevent further thrombus. 2023 Hebbo, Khoury, Iskandarani and Sawaya.
Description
Keywords
Acute coronary syndrome, Anticoagulation, Interventional cardiology. acute myocardial infarction, Thromboembolism, Transcatheter aortic valve replacement, Valve thrombus, Acetylsalicylic acid, Amlodipine, Bisoprolol, C reactive protein, Clopidogrel, Rivaroxaban, Troponin, Acute heart infarction, Aged, Angioplasty, Aortic dissection, Aortic stenosis, Aortic valve thrombosis, Article, Atherosclerosis, Atrioventricular block, Case report, Clinical article, Computed tomographic angiography, Coronary angiography, Electrocardiography, Female, Heart catheterization, Heart left ventricle ejection fraction, Heart ventricle fibrillation, Human, Hypokinesia, Kidney tumor, Leukocytosis, Nephrectomy, Non-obstructive coronary artery disease, Pericarditis, Thorax pain, Thrombosis, Transcatheter aortic valve implantation, Transitional cell carcinoma, Transthoracic echocardiography